A novel Gαs-binding protein, Gas-2 like 2, facilitates the signaling of the A2A adenosine receptor

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 12, 2013, Pages 3145-3154

  Wu, Yi Chih ^a,b,c   Lai, Hsing Lin ^c   Chang, Wei Cheng ^c   Lin, Jiun Tsai ^c   Liu, Yu Ju ^d   Chern, Yijuang ^b,c,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

A2A adenosine receptor; CAMP; G s; Gas 2 like 2

Indexed keywords

ADENOSINE A2A RECEPTOR; CYCLIC AMP; GROWTH ARREST SPECIFIC 2 LIKE PROTEIN 2; GROWTH ARREST SPECIFIC PROTEIN 6; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 84884684770     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.08.009     Document Type: Article

References (52)

1. Chern Y., King K., Lai H.L., Lai H.T. Molecular cloning of a novel adenosine receptor gene from rat brain. Biochem. Biophys. Res. Commun. 1992, 185:304-309.
2. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch. Pharmacol. 2000, 362:364-374.
3. Olah M.E. Identification of A2a adenosine receptor domains involved in selective coupling to Gs. Analysis of chimeric A1/A2a adenosine receptors. J. Biol. Chem. 1997, 272:337-344.
4. Kull B., Svenningsson P., Fredholm B.B. Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol. Pharmacol. 2000, 58:771-777.
5. Schiffmann S.N., Jacobs O., Vanderhaeghen J.J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 1991, 57:1062-1067.
6. Aoyama S., Kase H., Borrelli E. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist. J. Neurosci. 2000, 20:5848-5852.
7. Popoli P., Blum D., Domenici M.R., Burnouf S., Chern Y. A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's disease. Curr. Pharm. Des. 2008, 14:1500-1511.
8. Stone T.W., Ceruti S., Abbracchio M.P. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Handb. Exp. Pharmacol. 2009, 535-587.
9. Chou S.Y., Lee Y.C., Chen H.M., Chiang M.C., Lai H.L., Chang H.H., Wu Y.C., Sun C.N., Chien C.L., Lin Y.S., Wang S.C., Tung Y.Y., Chang C., Chern Y. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. J. Neurochem. 2005, 93:310-320.
10. Ju T.C., Chen H.M., Lin J.T., Chang C.P., Chang W.C., Kang J.J., Sun C.P., Tao M.H., Tu P.H., Chang C., Dickson D.W., Chern Y. Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease. J. Cell Biol. 2011, 194:209-227.
11. Chang Y.H., Conti M., Lee Y.C., Lai H.L., Ching Y.H., Chern Y. Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells. J. Neurochem. 1997, 69:1300-1309.
12. Huang N.K., Lin Y.W., Huang C.L., Messing R.O., Chern Y. Activation of protein kinase A and atypical protein kinase C by A(2A) adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells. J. Biol. Chem. 2001, 276:13838-13846.
13. Keuerleber S., Gsandtner I., Freissmuth M. From cradle to twilight: the carboxyl terminus directs the fate of the A(2A)-adenosine receptor. Biochim. Biophys. Acta. 2011, 1808:1350-1357.
14. Sun C.N., Cheng H.C., Chou J.L., Lee S.Y., Lin Y.W., Lai H.L., Chen H.M., Chern Y. Rescue of p53 blockage by the A(2A) adenosine receptor via a novel interacting protein, translin-associated protein X. Mol. Pharmacol. 2006, 70:454-466.
15. Gsandtner I., Charalambous C., Stefan E., Ogris E., Freissmuth M., Zezula J. Heterotrimeric G protein-independent signaling of a G protein-coupled receptor. Direct binding of ARNO/cytohesin-2 to the carboxyl terminus of the A2A adenosine receptor is necessary for sustained activation of the ERK/MAP kinase pathway. J. Biol. Chem. 2005, 280:31898-31905.
16. Burgueno J., Blake D.J., Benson M.A., Tinsley C.L., Esapa C.T., Canela E.I., Penela P., Mallol J., Mayor F., Lluis C., Franco R., Ciruela F. The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. J. Biol. Chem. 2003, 278:37545-37552.
17. Navarro G., Aymerich M.S., Marcellino D., Cortes A., Casado V., Mallol J., Canela E.I., Agnati L., Woods A.S., Fuxe K., Lluis C., Lanciego J.L., Ferre S., Franco R. Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. J. Biol. Chem. 2009, 284:28058-28068.
18. Canela L., Lujan R., Lluis C., Burgueno J., Mallol J., Canela E.I., Franco R., Ciruela F. The neuronal Ca(2+) -binding protein 2 (NECAB2) interacts with the adenosine A(2A) receptor and modulates the cell surface expression and function of the receptor. Mol. Cell. Neurosci. 2007, 36:1-12.
19. Sun C.N., Chuang H.C., Wang J.Y., Chen S.Y., Cheng Y.Y., Lee C.F., Chern Y. The A2A adenosine receptor rescues neuritogenesis impaired by p53 blockage via KIF2A, a kinesin family member. Dev. Neurobiol. 2010, 70:604-621.
20. Milojevic T., Reiterer V., Stefan E., Korkhov V.M., Dorostkar M.M., Ducza E., Ogris E., Boehm S., Freissmuth M., Nanoff C. The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol. Pharmacol. 2006, 69:1083-1094.
21. Brancolini C., Bottega S., Schneider C. Gas2, a growth arrest-specific protein, is a component of the microfilament network system. J. Cell Biol. 1992, 117:1251-1261.
22. Novikova S.I., He F., Bai J., Badan I., Lidow I.A., Lidow M.S. Cocaine-induced changes in the expression of apoptosis-related genes in the fetal mouse cerebral wall. Neurotoxicol. Teratol. 2005, 27:3-14.
23. Benetti R., Del Sal G., Monte M., Paroni G., Brancolini C., Schneider C. The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis. EMBO J. 2001, 20:2702-2714.
24. Brancolini C., Schneider C. Phosphorylation of the growth arrest-specific protein Gas2 is coupled to actin rearrangements during Go->G1 transition in NIH 3T3 cells. J. Cell Biol. 1994, 124:743-756.
25. Goriounov D., Leung C.L., Liem R.K. Protein products of human Gas2-related genes on chromosomes 17 and 22 (hGAR17 and hGAR22) associate with both microfilaments and microtubules. J. Cell Sci. 2003, 116:1045-1058.
26. Stroud M.J., Kammerer R.A., Ballestrem C. Characterization of G2L3 (GAS2-like 3), a new microtubule- and actin-binding protein related to spectraplakins. J. Biol. Chem. 2011, 286:24987-24995.
27. Brown N.H. Spectraplakins: the cytoskeleton's Swiss army knife. Cell 2008, 135:16-18.
28. Jefferson J.J., Leung C.L., Liem R.K. Plakins: goliaths that link cell junctions and the cytoskeleton. Nat. Rev. Mol. Cell Biol. 2004, 5:542-553.
29. Shih Y.P., Kung W.M., Chen J.C., Yeh C.H., Wang A.H., Wang T.F. High-throughput screening of soluble recombinant proteins. Protein Sci. 2002, 11:1714-1719.
30. Chou J.L., Huang C.L., Lai H.L., Hung A.C., Chien C.L., Kao Y.Y., Chern Y. Regulation of type VI adenylyl cyclase by Snapin, a SNAP25-binding protein. J. Biol. Chem. 2004, 279:46271-46279.
31. Chern Y., Lai H.L., Fong J.C., Liang Y. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Mol. Pharmacol. 1993, 44:950-958.
32. Palmer T.M., Stiles G.L. Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry 1997, 36:832-838.
33. Awad J.A., Johnson R.A., Jakobs K.H., Schultz G. Interactions of forskolin and adenylate cyclase. Effects on substrate kinetics and protection against inactivation by heat and N-ethylmaleimide. J. Biol. Chem. 1983, 258:2960-2965.
34. Perry S.J., Baillie G.S., Kohout T.A., McPhee I., Magiera M.M., Ang K.L., Miller W.E., McLean A.J., Conti M., Houslay M.D., Lefkowitz R.J. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 2002, 298:834-836.
35. Efendiev R., Samelson B.K., Nguyen B.T., Phatarpekar P.V., Baameur F., Scott J.D., Dessauer C.W. AKAP79 interacts with multiple adenylyl cyclase (AC) isoforms and scaffolds AC5 and -6 to alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors. J. Biol. Chem. 2010, 285:14450-14458.
36. Ferre S., Quiroz C., Woods A.S., Cunha R., Popoli P., Ciruela F., Lluis C., Franco R., Azdad K., Schiffmann S.N. An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr. Pharm. Des. 2008, 14:1468-1474.
37. Sexl V., Mancusi G., Holler C., Gloria-Maercker E., Schutz W., Freissmuth M. Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 1997, 272:5792-5799.
38. Gille A., Wenzel-Seifert K., Doughty M.B., Seifert R. GDP affinity and order state of the catalytic site are critical for function of xanthine nucleotide-selective Galphas proteins. J. Biol. Chem. 2003, 278:7822-7828.
39. Masters S.B., Miller R.T., Chi M.H., Chang F.H., Beiderman B., Lopez N.G., Bourne H.R. Mutations in the GTP-binding site of GS alpha alter stimulation of adenylyl cyclase. J. Biol. Chem. 1989, 264:15467-15474.
40. Shashidhar S., Lorente G., Nagavarapu U., Nelson A., Kuo J., Cummins J., Nikolich K., Urfer R., Foehr E.D. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 2005, 24:1673-1682.
41. Chakravarti B., Chattopadhyay N., Brown E.M. Signaling through the extracellular calcium-sensing receptor (CaSR). Adv. Exp. Med. Biol. 2012, 740:103-142.
42. Duvernay M.T., Wang H., Dong C., Guidry J.J., Sackett D.L., Wu G. Alpha2B-adrenergic receptor interaction with tubulin controls its transport from the endoplasmic reticulum to the cell surface. J. Biol. Chem. 2011, 286:14080-14089.
43. Ciruela F., Canela L., Burgueno J., Soriguera A., Cabello N., Canela E.I., Casado V., Cortes A., Mallol J., Woods A.S., Ferre S., Lluis C., Franco R. Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function. J. Mol. Neurosci. 2005, 26:277-292.
44. Lai H.L., Yang T.H., Messing R.O., Ching Y.H., Lin S.C., Chern Y. Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response. J. Biol. Chem. 1997, 272:4970-4977.
45. Wolter P., Schmitt K., Fackler M., Kremling H., Probst L., Hauser S., Gruss O.J., Gaubatz S. GAS2L3, a target gene of the DREAM complex, is required for proper cytokinesis and genomic stability. J. Cell Sci. 2012, 125:2393-2406.
46. Huang N.K., Lin J.H., Lin J.T., Lin C.I., Liu E.M., Lin C.J., Chen W.P., Shen Y.C., Chen H.M., Chen J.B., Lai H.L., Yang C.W., Chiang M.C., Wu Y.S., Chang C., Chen J.F., Fang J.M., Lin Y.L., Chern Y. A new drug design targeting the adenosinergic system for Huntington's disease. PLoS One 2011, 6:e20934.
47. Ciruela F., Burgueno J., Casado V., Canals M., Marcellino D., Goldberg S.R., Bader M., Fuxe K., Agnati L.F., Lluis C., Franco R., Ferre S., Woods A.S. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal. Chem. 2004, 76:5354-5363.
48. Ferre S., Ciruela F., Woods A.S., Lluis C., Franco R. Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci. 2007, 30:440-446.
49. Giampa C., Laurenti D., Anzilotti S., Bernardi G., Menniti F.S., Fusco F.R. Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease. PLoS One 2010, 5:e13417.
50. Giampa C., Middei S., Patassini S., Borreca A., Marullo F., Laurenti D., Bernardi G., Ammassari-Teule M., Fusco F.R. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease. Eur. J. Neurosci. 2009, 29:902-910.
51. Chase T.N., Bibbiani F., Bara-Jimenez W., Dimitrova T., Oh-Lee J.D. Translating A2A antagonist KW6002 from animal models to parkinsonian patients. Neurology 2003, 61:S107-S111.
52. Cunha G.M., Canas P.M., Melo C.S., Hockemeyer J., Muller C.E., Oliveira C.R., Cunha R.A. Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. Exp. Neurol. 2008, 210:776-781.